Among the vast diversity of dog breeds, the Nova Scotia Duck Tolling Retriever, affectionately known as the toller, exhibits a striking and concerning predisposition to Addison’s disease. This rare endocrine disorder disrupts the normal production of vital adrenal hormones such as cortisol and aldosterone, which are crucial for maintaining immune function, metabolism, and electrolyte balance. In the canine world, tollers develop Addison’s disease at an unusually high rate compared to other breeds, with affected individuals often experiencing juvenile-onset symptoms that lead to profound health challenges and significantly shortened lifespans.
Addison’s disease in dogs mirrors human pathology in many ways, particularly in its hypothesized autoimmune etiology. The immune system, which typically functions to defend against pathogens, mistakenly targets the adrenal glands, impairing their ability to secrete hormones essential for bodily homeostasis. This autoimmune destruction results in what is termed primary adrenal insufficiency. In tollers, this autoimmune destruction often extends beyond the adrenal glands, co-occurring with other immune-mediated diseases—a phenomenon known as multiple autoimmune syndrome. The severe, early manifestation of this disease in tollers highlights the need for a deeper genetic and immunological understanding.
In groundbreaking research published in the March 2026 issue of Scientific Reports, a team of scientists led by Professor Danika Bannasch at the UC Davis Weill School of Veterinary Medicine identified a genetic variant strongly linked to Addison’s disease in Nova Scotia Duck Tolling Retrievers. The study illuminates the role of the RESF1 gene, a previously unassociated genetic locus now found to be intimately connected with disease susceptibility in these dogs. This discovery opens a new frontier in deciphering the complex genetic architecture of autoimmune endocrinopathies in canines.
The RESF1 gene, while conserved among multiple species including humans, has eluded prior connection to Addison’s disease or syndromes involving multiple autoimmune disorders in human medicine. The canine findings, however, suggest that RESF1 warrants investigation as a candidate gene impacting adrenal autoimmune pathology in humans. Such cross-species genetic parallels underscore the immense potential of veterinary models in unveiling fundamental mechanisms of disease that transcend species boundaries.
The implications of this research are twofold. First, for veterinary medicine, it offers a viable genetic target for breeding strategies aimed at reducing the incidence of Addison’s disease among tollers. A commercial genetic test developed by the UC Davis Veterinary Genetics Laboratory now enables breeders to identify carriers of the deleterious RESF1 variant, facilitating informed mating decisions to prevent propagation of the disease-causing allele. This proactive approach represents a critical step toward eradicating juvenile-onset Addison’s disease in the breed.
Secondly, this study situates the Nova Scotia Duck Tolling Retriever as a natural animal model for studying multiple autoimmune syndrome. Given the similarity in disease manifestation and genetic underpinnings, tollers could provide invaluable insights into the pathogenesis of complex autoimmune conditions that affect both the endocrine system and other organ systems in humans. Such translational research holds promise for novel therapeutic interventions.
The research is a product of multi-institutional collaboration, blending expertise from UC Davis, Genentech, the University of Sydney, Uppsala University, and the University of Prince Edward Island. Researchers Amy Young, Zena Wolf, Angela Hughes, Anita Oberbauer, along with Oded Foreman, Claire Wade, Noa Safra, Kerstin Lindblad-Toh, and Shelley Burton, contributed to this comprehensive effort, harnessing advanced experimental techniques in genetics and immunology to unravel the disease’s complexity.
Experimental methodologies employed in this study included genome-wide association analyses and targeted sequencing to pinpoint the RESF1 variant. These techniques provided robust evidence correlating the genetic variant with the phenotypic manifestation of Addison’s disease in affected tollers. The controlled experimental design and the inclusion of international cohorts fortified the study’s validity, underscoring the reproducibility and broad relevance of the findings.
Beyond the immediate scientific community, this research commands attention from dog breeders, veterinarians, and pet owners alike. By integrating genetic testing into breeding programs, the Nova Scotia Duck Tolling Retriever Club of America, along with supporters such as the Canine Health Foundation and Morris Animal Foundation, aims to mitigate the disease’s devastating impact on one of the breed’s beloved attributes—their vitality and youthful exuberance.
The study also received partial funding from prominent organizations committed to advancing animal health and biomedical research, including the National Institutes of Health. This endorsement highlights the broader significance of canine genetic research as a conduit for understanding human disease mechanisms, reflecting a growing appreciation of comparative medicine in contemporary biomedical science.
In light of these findings, the future trajectory of Addison’s disease research in both veterinary and human medicine could pivot around the RESF1 gene. It represents a beacon guiding future investigations into gene-environment interactions, immune tolerance breakdown, and novel therapeutic targets for autoimmune adrenal insufficiency. The potential to improve diagnostic precision and treatment efficacy in both dogs and humans is a compelling outcome of this research.
Ultimately, this breakthrough elevates the stature of the Nova Scotia Duck Tolling Retriever beyond its traditional role as a hunting companion, positioning the breed as a key figure in the study of genetic and autoimmune diseases. This convergence of genetics, immunology, and veterinary clinical practice offers hope for affected dogs and enriches our understanding of autoimmune disorders, cementing a pivotal chapter in the annals of veterinary genetic research.
Subject of Research: Animals
Article Title: A variant in RESF1 is associated with Addison’s disease and multiple autoimmune syndrome in young Nova Scotia Duck Tolling Retrievers
News Publication Date: 12-Mar-2026
Web References: http://dx.doi.org/10.1038/s41598-026-42994-y
Keywords: Genetic disorders, Autoimmune disorders, Veterinary medicine, Genetics, Animal science, Addison’s disease, Multiple autoimmune syndrome, RESF1 gene, Nova Scotia Duck Tolling Retriever
Tags: Addison’s disease in dogsadvances in veterinary endocrinology geneticscanine autoimmune endocrine disorderscomparative pathology of Addison’s diseasegenetic markers for Addison’s diseasegenetic research on canine diseasesimmune system dysfunction in dogsjuvenile-onset Addison’s symptomsmultiple autoimmune syndrome in caninesNova Scotia Duck Tolling Retriever healthprimary adrenal insufficiency in dogstranslational research for human adrenal disorders
